Long-term trends in incidence, characteristics and prognosis of screen-detected and interval cancers in women participating in the Dutch breast cancer screening programme

Daniëlle E Ten Velde, Lucien E M Duijm, Maurice J C van der Sangen, Robert-Jan Schipper, Vivianne C G Tjan-Heijnen, Willem Vreuls, Luc J A Strobbe, Adri C Voogd*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

14 Downloads (Pure)

Abstract

BACKGROUND: No studies are available in which changes over time in characteristics and prognosis of patients with interval breast cancers (ICs) and screen-detected breast cancers (SDCs) have been compared. The aim was to study these trends between 1995 and 2018. METHODS: All women with invasive SDCs (N?=?4290) and ICs (N?=?1352), diagnosed in a southern mammography screening region in the Netherlands, were included and followed until date of death or 31 December 2022. RESULTS: The 5-year overall survival rate of women with SDCs increased from 91.4% for those diagnosed in 1995-1999 to 95.0% for those diagnosed in 2013-2018 (P?<?0.001), and from 74.8 to 91.6% (P?<?0.001) in the same periods for those with ICs. A similar trend was observed for the 10-year survival rates. After adjustment for changes in tumour characteristics, the hazard ratio (HR) for overall survival was 0.47 (95% confidence interval (CI): 0.38-0.59) for women with SDCs diagnosed in the period 2013-2018, compared to the women diagnosed in the period 1995-1999. For the women with ICs this HR was 0.27 (95% CI: 0.19-0.40). CONCLUSION: The prognosis of women with ICs has improved rapidly since 1995 and is now almost similar to that of women with SDCs.
Original languageEnglish
Pages (from-to)1561-1570
Number of pages10
JournalBritish Journal of Cancer
Volume130
Issue number9
Early online date2024
DOIs
Publication statusPublished - 18 May 2024

Fingerprint

Dive into the research topics of 'Long-term trends in incidence, characteristics and prognosis of screen-detected and interval cancers in women participating in the Dutch breast cancer screening programme'. Together they form a unique fingerprint.

Cite this